Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash Sells 23,221 Shares

Outset Medical, Inc. (NASDAQ:OM) SVP Marc Nash sold 23,221 shares of the company’s stock in a transaction that occurred on Tuesday, January 21st. The stock was sold at an average price of $0.80, for a total value of $18,576.80. Following the transaction, the senior vice president now directly owns 204,968 shares in the company, valued at $163,974.40. The trade was a 10.18 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.

Marc Nash also recently made the following trade(s):

• On Monday, January 13th, Marc Nash sold 15,011 shares of Outset Medical stock. The shares were sold at an average price of $0.81, for a total value of $12,158.91.
• On Tuesday, January 7th, Marc Nash sold 720 shares of Outset Medical stock. The stock was sold at an average price of $1.29, for a total transaction of $928.80.
• On Friday, November 15th, Marc Nash sold 1,375 shares of Outset Medical stock. The stock was sold at an average price of $0.80, for a total transaction of $1,100.00.

Outset Medical Stock Performance

Shares of OM stock opened at $0.85 on Friday. The firm’s 50-day simple moving average is $1.01 and its two-hundred day simple moving average is $1.26. The company has a quick ratio of 5.04, a current ratio of 6.49 and a debt-to-equity ratio of 4.12. Outset Medical, Inc. has a 52 week low of $0.44 and a 52 week high of $5.22.

Hedge Funds Weigh In On Outset Medical

Several institutional investors have recently bought and sold shares of the company. National Bank of Canada FI raised its stake in shares of Outset Medical by 79.2% in the third quarter. National Bank of Canada FI now owns 52,407 shares of the company’s stock valued at $35,000 after buying an additional 23,164 shares during the period. Huntington National Bank increased its holdings in Outset Medical by 46.2% in the 3rd quarter. Huntington National Bank now owns 63,306 shares of the company’s stock worth $43,000 after acquiring an additional 20,000 shares during the last quarter. Vanguard Personalized Indexing Management LLC bought a new stake in Outset Medical in the 2nd quarter valued at about $49,000. Point72 Asia Singapore Pte. Ltd. bought a new stake in shares of Outset Medical in the second quarter valued at approximately $259,000. Finally, Squarepoint Ops LLC boosted its holdings in Outset Medical by 74.1% in the 2nd quarter. Squarepoint Ops LLC now owns 80,300 shares of the company’s stock worth $309,000 after buying an additional 34,187 shares during the period.

Wall Street Analyst Weigh In

Separately, Royal Bank of Canada reaffirmed a “sector perform” rating and set a $3.00 price target on shares of Outset Medical in a research report on Tuesday, January 7th.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.